Get the Stockscreener App
59.54
1.30%
1.22
Atricure Inc stock is traded at $59.54, with a volume of 358.78K.
It is up +1.30% in the last 24 hours and up +20.62% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$58.32
Open:
$58.62
24h Volume:
358.78K
Relative Volume:
0.38
Market Cap:
$3.03B
Revenue:
$534.53M
Net Income/Loss:
$-11.45M
P/E Ratio:
-246.95
EPS:
-0.2411
Net Cash Flow:
$48.28M
1W Performance:
+5.09%
1M Performance:
+20.62%
6M Performance:
+102.50%
1Y Performance:
+57.46%
1-Day Range:
$57.94
$59.69
1-Week Range:
$55.66
$59.88
52-Week Range:
$25.36
$59.88
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
59.50 | 2.77B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
399.23 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
181.62 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.47 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.46 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.02 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) CTO sells stock under preset plan - Stock Titan
Biotech Stocks At 52-Week HighsATTO, HALO, IKT, TVTX, ATRC - RTTNews
A Look at AtriCure Inc (ATRC) After 7.5% Gain -- GF Value $39.67 vs Price $52.59 - GuruFocus
ATRC Maintains by Needham -- Price Target Raised to $64.00 - GuruFocus
AtriCure Price Target Raised to $64.00/Share From $45.00 by Needham - Moomoo
Atricure stock hits 52-week high at $50.00 By Investing.com - Investing.com Nigeria
Atricure stock hits 52-week high at $50.00 - Investing.com
Needham raises AtriCure stock price target on trial outlook - Investing.com
Needham raises AtriCure stock price target on trial outlook By Investing.com - Investing.com Nigeria
AtriCure Inc. (ATRC) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
AtriCure (ATRC) Slips 1.48% to $48.54 as Shares Navigate Key Trading RangeVolatility Skew - vinanet.vn
AtriCure Inc. (ATRC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Atrial Fibrillation Surgery Market Companies, Size & Trends 2026-2035 - Precedence Research
ATRC Maintained Overweight by Piper Sandler -- Price Target Rais - GuruFocus
Piper Sandler raises AtriCure stock price target on quality measure By Investing.com - Investing.com Nigeria
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60 - moomoo.com
AtriCure chief legal officer sells $458,099 in stock By Investing.com - Investing.com Nigeria
Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing - marketscreener.com
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic - Yahoo Finance
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Yahoo Finance
BTIG raises AtriCure stock price target on new quality metric By Investing.com - Investing.com Canada
BTIG raises AtriCure stock price target on new quality metric - Investing.com
AtriCure (ATRC) Financial Results: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):